Trial intelligence / Profile preview

Postoperative delirium and recovery quality with remimazolam vs propofol in elderly major abdominal surgery

KCT0006877Phase 4Completed

Sponsor
Hana Pharm
Start
Aug 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of remimazolam, propofol in delirium, Neoplasm, None, sponsored by Hana Pharm. Started Aug 2022; status: completed.

02

Drugs

remimazolampropofol
03

Conditions

deliriumNeoplasm

Beyond the preview

Go deeper on KCT0006877.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0006877.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call